B16F10 murine melanoma modelImmune checkpoint inhibitorsanti-PD1
… viral vector nAg vaccine was developed and administered in the B16F10 murine melanoma model. Mice received the vaccine either before (neoadjuvant) or after…
1articles mentioning institutions
1institution mentions
1distinct institutions extracted
0%of mentions human-reviewed
Active filtersEntity: B16F10 murine melanoma model ×
B16F10 murine melanoma model
This institution is selected. Its supporting articles are shown below.